Increased cyclooxygenase 2 expression in association with oral lichen planus severity  by Chankong, Thaneeya et al.
Journal of Dental Sciences (2016) 11, 238e244Available online at www.sciencedirect.com
ScienceDirect
journal homepage: www.e- jds.comORIGINAL ARTICLEIncreased cyclooxygenase 2 expression in
association with oral lichen planus severity
Thaneeya Chankong, Pareena Chotjumlong,
Thanapat Sastraruji, Surawut Pongsiriwet, Anak Iamaroon,
Suttichai Krisanaprakornkit*Center of Excellence in Oral and Maxillofacial Biology, Department of Oral Biology and Diagnostic
Sciences, Faculty of Dentistry, Chiang Mai University, Chiang Mai, ThailandReceived 16 November 2015; Final revision received 14 December 2015
Available online 8 April 2016KEYWORDS
cyclooxygenase 2;
immunohistochemistry;
oral lichen planus;
visual analog pain scale* Corresponding author. Center of E
Faculty of Dentistry, Chiang Mai Unive
E-mail address: suttichai.k@cmu.a
http://dx.doi.org/10.1016/j.jds.2015.1
1991-7902/Copyrightª 2016, Associati
article under the CC BY-NC-ND license (Abstract Background/purpose: Although some studies have shown induction of cycloox-
ygenase 2 (COX-2) in oral lichen planus (OLP), an association between COX-2 upregula-
tion and OLP clinical severity has not been investigated. Therefore, we aimed to
compare COX-2 expression in OLP with that in normal oral tissues, and to determine cor-
relations between COX-2 expression and both clinical criteria and visual analog scale
(VAS) scores.
Materials and methods: COX-2 expression was studied in 25 OLP and 13 normal oral tis-
sues by immunohistochemistry. Both clinical criteria and VAS scores were used to eval-
uate the clinical severity of OLP. The differences in COX-2 expression between OLP
and normal tissues, and the correlations between COX-2 expression and clinical severity
were determined by the nonparametric statistical tests.
Results: COX-2 expression was significantly increased in OLP epithelium when compared
with normal epithelium (P < 0.001), and intense COX-2 staining in inflammatory infiltrates
was observed in the OLP lamina propria. COX-2 expression in OLP epithelium and inflam-
matory infiltrates was significantly correlated with the clinical criteria score (r Z 0.428,
P Z 0.007, and r Z 0.681, P < 0.001, respectively), whereas a significant correlation
with the VAS score was observed only in OLP inflammatory infiltrates (r Z 0.605,
P < 0.001).
Conclusion: Enhanced COX-2 expression in both OLP epithelium and inflammatory infil-
trates correlates well with the clinical severity. An association between VAS score andxcellence in Oral and Maxillofacial Biology, Department of Oral Biology and Diagnostic Sciences,
rsity, Suthep Road, Suthep Subdistrict, Muang District, Chiang Mai 50200, Thailand.
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Enhanced COX-2 expression in OLP 239COX-2 expression in OLP inflammatory infiltrates suggests an important role of additional
COX-2 expression from inflammation in causing pain in OLP patients.
Copyright ª 2016, Association for Dental Sciences of the Republic of China. Published by
Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Oral lichen planus (OLP), a chronic inflammatory lesion, is
commonly found in the adult population and affects
women more than men.1e3 The ratio of female to male
varies across different geographical areas, and this ratio
can be as high as 4:1 in Thai patients.4 Usually, OLP pa-
tients seek therapy because of burning sensation from
atrophic or ulcerative epithelium, caused by epithelial
apoptosis.5,6 The definitive diagnosis of OLP is confirmed
by the histopathologic features of epithelial hyperkerato-
sis, subepithelial band-like mononuclear infiltration, and
liquefaction degeneration of the basal and parabasal
cells.7 OLP etiology is multifactorial and involves an ab-
erration of T-cell-mediated immune responses to unknown
foreign antigens,6 such as dental materials, drugs, and
bacterial and viral infections. Different intrinsic factors
within individual patients are also implicated in the
etiology.6e8
Cyclooxygenase 2 (COX-2) is a 72-kDa inducible enzyme
essential for prostaglandin production. With respect to
oral diseases, COX-2 expression is shown to be upregu-
lated in oral squamous cell carcinoma (OSCC)9,10 and
chronic inflammatory disorders, including gingivitis, peri-
odontitis, apical periodontitis, and OLP.11,12 Enhanced
COX-2 expression is shown in different cell types ranging
from normal cells to cancer cells in these diseases.
Moreover, COX-2 induction is proposed to be involved with
malignant transformation.13 Neppelberg and Johannes-
sen12 have, instead, suggested that COX-2 expression
cannot be used as a reliable marker for malignant trans-
formation in OLP.
Eight previous studies have demonstrated COX-2
expression in OLP,12,14e20 but only four studies have
shown a significant increase in COX-2 expression in OLP
lesions compared with normal tissues.14e16,18 Out of these
four studies, only one16 has reported differences in COX-2
expression between different types of OLP. Particularly, a
significantly greater COX-2 expression was found in the
ulcerative/erosive type than in the atrophic type. There-
fore, it is possible that different classification systems and
definitions used to categorize OLP types and severities are
involved in the inconsistent findings. In 1992, Thongpra-
som and coworkers21 proposed the clinical criterion to
evaluate OLP severity. This criterion has been well
accepted; we, therefore, used it as a tool to clinically
evaluate OLP types and severities. In this study, we aimed
to compare COX-2 expression in OLP lesions with that in
normal oral tissues by immunohistochemistry, and to find
correlations between COX-2 expression and OLP severity,
assessed by the clinical criteria and visual analog scale
(VAS)22 scores.Materials and methods
Patient selection
Twenty-five new patients clinically and histopathologically
confirmed to have OLP were recruited from the Oral Medi-
cine Clinic, Faculty of Dentistry, Chiang Mai University,
Chiang Mai, Thailand. The inclusion criteria were as follows:
(1) patients clinically presented with a white and/or red
oral lesion that was later confirmed histologically as OLP
without evidence of dysplastic changes; (2) patients did not
have a history of taking drugs that are reported to cause
lichenoid drug reactions and the OLP lesion was not adja-
cent to dental restoration2,23; and (3) patients have neither
other oral mucosal lesions nor a history of lichenoid-related
systemic conditions. The exclusion criteria were as follows:
patients who had received systemic or topical steroid
treatment for oral lesions in the past 3 months and those
who were pregnant or breast-feeding. The demographic
data on age, gender, and site of the lesion for patients with
OLP are summarized in Table 1. The research protocol was
approved, and a certificate of ethical clearance (#16/2014)
was issued by the Human Experimentation Committee,
Faculty of Dentistry, Chiang Mai University. Informed con-
sent was obtained prior to sample collection.
Assessment of OLP severity and collection of tissue
specimens
The clinical severity of OLP was evaluated by the VAS22 and
clinical criteria scores.21 The VAS score was obtained from
each patient at the first visit to subjectively describe his or
her pain using a 0e10 scale, where 0 indicates no pain and
10 the worst imaginable pain. The clinical criteria score was
given for the most severe site of OLP as follows: 0 Z no
lesion, normal mucosa; 1 Z mild white striae, no
erythematous area; 2 Z white striae with an atrophic area
smaller than 1 cm2; 3 Z white striae with an atrophic area
larger than 1 cm2; 4Z white striae with an ulcerative area
smaller than 1 cm2; and 5Z white striae with an ulcerative
area larger than 1 cm2. An incisional biopsy was conducted
at the most severe site of OLP, as a representative area for
each patient, fixed in 10% formalin buffer for 24 hours, and
embedded in paraffin blocks. The OLP specimens were
sectioned for a definitive histopathologic diagnosis by he-
matoxylin and eosin staining.
Immunohistochemistry
Twenty-five OLP specimens as well as 13 normal oral
specimens from both vestibular and buccal mucosae,
Table 1 Demographic data and sites of lesions in patients with OLP.
Group No. of
participants
Gender (%) Mean age, y
(range)
Site of lesion (%)
Male Female Buccal
mucosa
Gingiva Mucobuccal
fold
Tongue Labial
mucosa
Multiple
sites
OLP 25 5 (20.0) 20 (80.0) 48.76 (19e69) 25 (100.0) 7 (28.0) 6 (24.0) 2 (8.0) 2 (8.0) 10 (40.0)
OLP Z oral lichen planus.
240 T. Chankong et alretrieved from the archives of the Dental Hospital, Faculty
of Dentistry, Chiang Mai University, were serially cut at
5 mm thickness and processed by immunohistochemistry
according to our previously published protocol.24 The sec-
tions were deparaffinized, gradually rehydrated, and
quenched for the tissue peroxidase activity by incubation in
3% H2O2 for 10 minutes. Antigen retrieval was performed by
heating the sections in 1mM EDTA for 15 minutes and left at
room temperature for 20 minutes. The sections were
incubated in 1.5% normal horse serum for 20 minutes and
with the mouse monoclonal antibody specific for COX-2 at
1:50 dilution (sc-166475; Santa Cruz Biotechnology, Santa
Cruz, CA, USA) at 4C overnight. Thereafter, the sections
were reacted with the biotinylated antimouse antibody
(Ready-to-Use (R.T.U.) Vectastain elite ABC kit; Vector
Laboratories, Burlingame, CA, USA) for 20 minutes, and
incubated with avidin-biotinylated horseradish peroxidase
(ImmunoCruz ABC Staining Systems; Santa Cruz Biotech-
nology) for 20 minutes at room temperature. The sections
were stained with 3,30-diaminobenzidine (Vector Labora-
tories) for 4 minutes and then counterstained with hema-
toxylin for 20 seconds. The OLP section, in which the
primary antibody was omitted and replaced with normal
horse serum, was used as a negative control. The section
with a histopathologic diagnosis of OSCC, retrieved from
the Dental Hospital, was used as a positive control for COX-
2 staining.9 Digitalized images were captured by a charge-
coupled device camera (D70; Olympus, Tokyo, Japan),
attached to a bright-field microscope (BX41; Olympus) and
a computer desktop system.Determination of immunohistochemical staining
scores
The scoring for each section was performed under Image J
program twice by two observers who were blinded to its
clinicopathological data. The intra- and interexaminer
calibrations were performed with Cohen’s kappa values
equal to 0.90 and 0.85, respectively. Before scoring, each
section was first observed to determine the orientation of
epithelium and connective tissue, and then screened for a
selection of five fields of vision in the epithelial and con-
nective tissue layers, representing the characteristics of
each section. Then, the scoring was performed in the
epithelial and connective tissue layers under 200 magni-
fication power. The staining intensities were scored as
follows: 0 Z no staining, 1 Z weak, 2 Z moderate, and
3Z strong. Brown staining in the cytoplasm was considered
to be positive regardless of the staining intensity. The
number of positive cells in each field was counted, and the
percentage of positive cells was calculated by dividing itsnumbers with the total number of cells in each field. Then,
the average percentage of positive cells was calculated
from five fields of vision. The immunohistochemical staining
score (0e3),25 measured as (staining intensity
score)  (percentage of positive cells), was determined for
COX-2 expression in both epithelial layer and inflammatory
infiltrates.Statistical analyses
The ManneWhitney U test was used to compare COX-2
expression between OLP and normal oral tissues. The
Spearman or Pearson correlation coefficient was used to
determine correlations between COX-2 expression and the
clinical criteria or the VAS score, respectively. SPSS soft-
ware version 17.0 for Windows (IBM, Chicago, IL, USA) was
used for all statistical analyses.Results
Clinical findings
The chief complaints of OLP patients included burning
sensation (76%) and pain (12%), and they were without any
symptoms for the reticular type of OLP (12%). The VAS score
ranged from 0 to 9.6, with a mean VAS score  standard
deviation being equal to 2.87  3.17. When OLP and normal
oral specimens were grouped by the clinical criteria score,
there were 13 normal oral tissues with score 0 for no lesion;
four OLP tissues with score 1 for reticular OLP; seven and
six OLP tissues with scores 2 and 3, respectively, for atro-
phic OLP; and seven OLP tissues and one OLP tissue with
scores 4 and 5, respectively, for ulcerative OLP.Increased COX-2 expression in OLP
By immunohistochemistry, COX-2 expression was found in
the cytoplasm of the epithelial cells (brown staining) in all
sections from both OLP and normal tissues (Figure 1), but
COX-2 expression, assessed by the immunohistochemical
staining score, in OLP epithelium was significantly greater
than that in normal epithelium (P < 0.001; Figure 2A).
Intense staining of COX-2 expression was also detected in a
band-like inflammatory infiltrate in the OLP lamina propria
(Figure 1), consistent with a significant increase in COX-2
expression in the inflammatory infiltrates of OLP lesions
(P < 0.001; Figure 2B). As a negative control, the OLP
section, in which the primary antibody against COX-2 was
omitted, showed no staining, whereas intense staining of
Figure 1 Increased COX-2 expression in OLP. COX-2 expression (brown staining in the cytoplasm) in OLP epithelium was greater
than that in normal epithelium. Note intense COX-2 staining in OLP inflammatory infiltrates in the lamina propria. The OLP section,
in which the primary antibody against COX-2 was omitted, showed no staining as a negative control. As a positive control for COX-2
expression, the OSCC specimen showed intense brown staining in the cancer cells and stromal inflammatory cells. Original
magnification, 200. COX-2 Z cyclooxygenase 2; OLP Z oral lichen planus; OSCC Z oral squamous cell carcinoma.
Enhanced COX-2 expression in OLP 241COX-2 expression was found in the OSCC specimen, which
served as a positive control (Figure 1).
Enhanced COX-2 expression in relation to the
clinical severity of OLP
COX-2 staining in both OLP epithelium and inflammatory
infiltrates was more intense in the higher clinical criteria
scores (scores 3e5) than in the lower clinical criteria
scores (scores 0e2; Figure 3). Moreover, significant and
positive correlations were demonstrated between the
clinical criteria score and COX-2 expression in both OLP
epithelium and inflammatory infiltrates (r Z 0.428,
PZ 0.007, and rZ 0.681, P < 0.001, respectively; Figures
4A and 4B). A significant and positive correlation was found
between the VAS score and COX-2 expression in OLP in-
flammatory infiltrates (r Z 0.605, P < 0.001; Figure 4D),
whereas no significant correlation was found between the
VAS score and COX-2 expression in OLP epithelium
(Figure 4C).
Discussion
In this study, we demonstrated a significant increase of
COX-2 expression in OLP epithelium compared with that in
normal oral epithelium by immunohistochemistry. This
finding is in line with the results of previous studies.12,18,19
In addition to increased COX-2 expression in OLPepithelium, we found intense COX-2 staining in OLP in-
flammatory infiltrates similar to the results of several
studies.12,15,17e20 However, all those studies have not yet
shown the correlations between increased COX-2 expres-
sion in both OLP epithelium and inflammatory infiltrates
and the clinical severity of OLP. Therefore, our correlation
data in Figure 4 have further extended their results by
showing significant and positive relationships between
enhanced COX-2 expression in OLP epithelium and inflam-
matory infiltrates and OLP severity, represented by the
clinical criteria and the VAS scores.
Clinically, burning sensation or pain symptoms in pa-
tients with OLP may be explained by high levels of COX-2
expression in both OLP epithelium and inflammatory in-
filtrates accumulating in the OLP lamina propria because an
important function of the COX-2 enzyme is to produce
PGE2, which is considered to be one of the pain mediators.
In the chronic ulcerative/erosive lesions of OLP, elevated
PGE2 levels can probably sensitize peripheral sensory
nerves, causing pain signals to be readily and more
frequently transmitted to the brain,26,27 resulting in more
pain and higher VAS scores in the ulcerative/erosive type of
OLP than those in the other types. Accordingly, a significant
and positive correlation between intense COX-2 staining in
OLP inflammatory infiltrates and the VAS score in Figure 4D
is consistent with the aforementioned explanation and with
the findings from a previous study16 that revealed signifi-
cantly higher PGE2 levels in the ulcerative/erosive type
than in the atrophic type of OLP.
Figure 2 Significant increase in COX-2 expression, as evaluated by the IHC staining score in both (A) OLP epithelium and (B)
inflammatory infiltrates. The box-plot graphs demonstrated a significantly higher COX-2 expression in OLP epithelium and in-
flammatory infiltrates than in normal oral mucosa. The horizontal lines in each box plot represent the 25th percentile, 50th
percentile, and 75th percentile of COX-2 expression. *P < 0.001. COX-2 Z cyclooxygenase 2; IHC Z immunohistochemical;
OLP Z oral lichen planus.
242 T. Chankong et alT lymphocytes are predominantly found in the band-like
inflammatory infiltrates of OLP lesions.28 One of the
adverse outcomes for T lymphocyte infiltration is degra-
dation of basal lamina by production and secretion ofFigure 3 Various degrees of COX-2 expression in different clinica
criteria score (0e5) is shown for COX-2 staining. Note the most in
infiltrates for the clinical criteria score 5. Original magnification, 2matrix metalloproteinase 9.5,29 The basement membrane
destruction can thus lead to infiltration of T lymphocytes
into the OLP epithelial layer, resulting in direct cell-to-cell
contacts between epithelial cells and T lymphocytes thatl criteria scores. The representative section from each clinical
tense COX-2 staining in OLP epithelial cells and inflammatory
00. COX-2 Z cyclooxygenase 2; OLP Z oral lichen planus.
Figure 4 Correlation data between COX-2 expression in (A
and C) OLP epithelium and (B and D) inflammatory infiltrates,
as assessed by the IHC staining score on the y-axis, and (A and
B) the clinical criteria score and (C and D) the VAS score on the
x-axis. Note the significant and positive correlations found
between (A and B) COX-2 expression in OLP epithelium and
inflammatory infiltrates and the clinical criteria score, and
between COX-2 expression in OLP inflammatory infiltrates and
the VAS score (the regression line in D). COX-
2 Z cyclooxygenase 2; IHC Z immunohistochemical;
OLP Z oral lichen planus; VAS Z visual analog scale.
Enhanced COX-2 expression in OLP 243can lead to apoptosis of OLP epithelial cells.7,30 Increased
epithelial apoptosis was clinically observed as the atrophic
and the ulcerative/erosive type of OLP,31 in which they
were scored as 2, 3, 4, and 5 according to the clinical
criteria score. Therefore, an increase in COX-2 expression
in OLP epithelium in the clinical criteria scores 3, 4, and 5
(Figure 3) suggests that overwhelming COX-2 expression inthese scores may cause a nonhealing wound in OLP
epithelium. This speculation is consistent with the previous
finding that demonstrated an increase in epithelial
apoptosis in the ulcerative/erosive type of OLP.31 Inter-
estingly, COX-2 was also weakly expressed in the suprabasal
cell layers of normal oral epithelium (Figure 1), which is in
line with the findings from other studies in normal oral
epithelium32,33 and in normal epidermis.34
To accurately compare clinical severities and in-
terventions among different OLP studies, a single, well-
accepted clinical criterion is required. A recent meta-
analysis study has indicated that 25% of OLP studies used
Thongprasom et al’s35 clinical criterion to assess OLP
severity and treatment efficacy. Therefore, this criterion
was selected to evaluate OLP severity, and a significant
correlation was found between increased COX-2 expression
in OLP epithelium and inflammatory infiltrates and the
clinical criteria score. In conclusion, enhanced COX-2
expression in both OLP epithelium and inflammatory in-
filtrates is significantly correlated with OLP severity.
Moreover, a strong correlation between COX-2 staining in
OLP inflammatory infiltrates and the VAS score suggests
that additional COX-2 expression in OLP inflammatory in-
filtrates may play a causative role in burning sensation or
pain in patients with the atrophic or ulcerative/erosive
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